Abstract
Objective: To characterise the relative effects of once-weekly dulaglutide (DU) and active comparators on change in HbA1c across the continuous range of baseline HbA1c values.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
